Market Share

Showing 3061 articles
Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

Brunswick Charts Steady Course as Marine Market Rebounds, Touts Record Cash Flow and Debt Reduction

Brunswick Corporation (NYSE: BC) closed its 2025 fiscal year on a confident note, citing a resilient recovery in the marine market, a historic surge in free cash flow, and significant debt reduction. While navigating persistent tariff headwinds, the company's leadership pointed to stabilizing retail demand and strategic market share gains as key drivers for cautious optimism heading into 2026.